Hap Trading, LLC Oramed Pharmaceuticals Inc. Call Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$3.72 - $9.0 $40,548 - $98,100	-10,900 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$8.19 - $13.89 $89,271 - $151,401	10,900 New	10,900 $4,000
Q4 2021 Feb 14, 2022	SELL	$12.98 - $29.75 $669,768 - $1.54 Million	-51,600 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$12.13 - $23.82 $908,537 - $1.78 Million	-74,900 Reduced 59.21%	51,600 $729,000
Q2 2021 Aug 11, 2021	BUY	$8.34 - $14.59 $565,452 - $989,202	67,800 Added 115.5%	126,500 $716,000
Q1 2021 May 14, 2021	BUY	$4.22 - $11.33 $193,698 - $520,047	45,900 Added 358.59%	58,700 $157,000
Q4 2020 Feb 16, 2021	BUY	$2.48 - $4.64 $31,744 - $59,391	12,800 New	12,800 $5,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.4M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.